News outlets discuss President Barack Obama’s plan to request additional funding to combat and prevent antibiotic drug resistance.

The Hill: Obama eyes new funds to fight antibiotic-resistant bacteria
“President Obama will propose nearly doubling the amount of federal funding to combat antibiotic-resistant bacteria in his budget proposal, the White House said Tuesday…” (Sink, 1/27).

Reuters: Obama’s ‘precision medicine’ plan to boost research, but faces hurdles
“President Barack Obama’s plan to put the United States at the forefront of individually tailored medical treatment should give a much-needed boost to research in the field but experts say it won’t work without reforms to health care, including drug testing and insurance…” (Begley/Clarke, 1/28).

ScienceInsider: White House plans big 2016 budget ask to fight antibiotic resistance
“…A fact sheet released [Tuesday] describes how President Barack Obama plans to double the government’s investment in combating the mounting public health crisis of drug-resistant infections by spreading roughly $1.2 billion in funding across several federal agencies…” (Servick, 1/27).

Xinhua: Obama seeks to double funding to combat antibiotic-resistant bacteria
“…The Obama administration also issued a national strategy on combating antibiotic-resistant bacteria, which outlines steps the U.S. government will take to improve prevention, detection, and control of resistant pathogens” (1/27).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

KFF Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KFF | twitter.com/kff

The independent source for health policy research, polling, and news, KFF is a nonprofit organization based in San Francisco, California.